Minnetronix Medical has been selected as the medical device technology partner for the Oculogica EyeBOX, a medical device used as an aid in diagnosing concussion.
Minnetronix was chosen by Oculogica for its complex optical systems knowledge, integrated optical manufacturing and line testing capabilities, and strategic supply chain management experience.
EyeBOX uses ocular motility and other domains of brain function to detect concussion. It is the only FDA-cleared objective diagnostic based on cranial nerve function and its relation to eye movement. Minnetronix provided Oculogica with a streamlined production transfer process that reduced risks and accelerated time to market.
Within Minnetronix’ dedicated New Production Introduction space designed to accelerate manufacturing start-ups, the team quickly developed, qualified, and scaled manufacturing of the device from early phase builds through commercial production, supporting a fast-tracked timeline from manufacturing transfer in fall of 2021 to launching commercially available products in February 2022, shortly after EyeBOX obtained FDA clearance.
Minnetronix’ holistic approach also included creative solutions to overcome supply chain challenges, such as recommending a unique development solution aimed at optimising unit cost and component availability for the circuit boards used in the device.
Matt Adams, vice president and general manager at Minnetronix, said: “We took the process development, engineering, manufacturing, and supply chain burden off Oculogica so they could focus on the big picture of preparing to launch and commercialise the EyeBOX and grow their business. Our comprehensive approach and deep optical systems expertise made us best positioned to help Oculogica accelerate its path to market under tight deadlines.”
Rosina Samadani, PhD, CEO of Oculogica, added: “Their experience with complex optical systems, manufacturing capabilities, and focus on innovation made Minnetronix a natural fit for us. This partnership enabled us to bring our latest technology to market quickly and efficiently.”
The Minnetronix work on the EyeBOX comes on the heels of its recent partnership announcement with optics research firm INO.
